FI105153B - Menetelmä farmaseuttisten, suun kautta annettavien dideoksipuriininukleosidikoostumusten valmistamiseksi - Google Patents

Menetelmä farmaseuttisten, suun kautta annettavien dideoksipuriininukleosidikoostumusten valmistamiseksi Download PDF

Info

Publication number
FI105153B
FI105153B FI923308A FI923308A FI105153B FI 105153 B FI105153 B FI 105153B FI 923308 A FI923308 A FI 923308A FI 923308 A FI923308 A FI 923308A FI 105153 B FI105153 B FI 105153B
Authority
FI
Finland
Prior art keywords
magnesium
tablet
insoluble
antacid
water
Prior art date
Application number
FI923308A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI923308A (fi
FI923308A0 (fi
Inventor
Ismat Ullah
Shreeram Narahari Agharkar
Gary James Wiley
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27112590&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI105153(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of FI923308A0 publication Critical patent/FI923308A0/fi
Publication of FI923308A publication Critical patent/FI923308A/fi
Application granted granted Critical
Publication of FI105153B publication Critical patent/FI105153B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
FI923308A 1991-07-22 1992-07-20 Menetelmä farmaseuttisten, suun kautta annettavien dideoksipuriininukleosidikoostumusten valmistamiseksi FI105153B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73354791A 1991-07-22 1991-07-22
US73354791 1991-07-22
US88220492A 1992-05-13 1992-05-13
US88220492 1992-05-13

Publications (3)

Publication Number Publication Date
FI923308A0 FI923308A0 (fi) 1992-07-20
FI923308A FI923308A (fi) 1993-01-23
FI105153B true FI105153B (fi) 2000-06-30

Family

ID=27112590

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923308A FI105153B (fi) 1991-07-22 1992-07-20 Menetelmä farmaseuttisten, suun kautta annettavien dideoksipuriininukleosidikoostumusten valmistamiseksi

Country Status (23)

Country Link
US (1) US5880106A (zh)
EP (1) EP0524579B1 (zh)
JP (1) JP3038456B2 (zh)
KR (1) KR960011772B1 (zh)
CN (1) CN1042299C (zh)
AT (1) ATE163855T1 (zh)
AU (1) AU657337B2 (zh)
CA (1) CA2074215C (zh)
DE (1) DE69224684T2 (zh)
DK (1) DK0524579T3 (zh)
ES (1) ES2113389T3 (zh)
FI (1) FI105153B (zh)
GR (1) GR3026332T3 (zh)
HU (3) HU9202318D0 (zh)
IE (1) IE922365A1 (zh)
IL (1) IL102519A (zh)
MX (1) MX9204256A (zh)
NO (1) NO300198B1 (zh)
NZ (1) NZ243567A (zh)
PL (1) PL295329A1 (zh)
RU (1) RU2089193C1 (zh)
TW (1) TW211521B (zh)
ZA (1) ZA925484B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA69413C2 (uk) * 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
IL134592A0 (en) * 1998-06-18 2001-04-30 Univ George Washington Compositions comprising camptothecin compounds for the treatment of cancer with reduced side effects
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
US20040028772A1 (en) * 2000-08-14 2004-02-12 Carsten Andersen Method for preparation of chewing gum with customer acceptable taste
US6887926B1 (en) 2001-11-16 2005-05-03 Oatey Co. Bonding compositions for chlorinated polymers and methods of using the same
CN100415211C (zh) * 2003-07-03 2008-09-03 上海现代药物制剂工程研究中心 抗艾滋病药去羟肌苷的肠溶微粒组合物及制备方法
US20080299227A1 (en) * 2007-05-30 2008-12-04 Sunhealth Therapies, Inc. Method for removal of HIV from the gastrointestinal tract and bile of HIV-infected subjects and for the prevention of drug failure and prevention of development of AIDS in HIV-infected subjects
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
EA201100851A1 (ru) 2008-12-23 2012-04-30 Фармассет, Инк. Аналоги нуклеозидов
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
NZ593648A (en) 2008-12-23 2013-09-27 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
BR112012024884A2 (pt) 2010-03-31 2016-10-18 Gilead Pharmasset Llc síntese estereosseletiva de ativos contendo fósforo
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
EP2609923B1 (en) 2010-03-31 2017-05-24 Gilead Pharmasset LLC Process for the crystallisation of (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
EP2428201A1 (en) 2010-09-08 2012-03-14 Merck Serono S.A. Oral administration of nucleoside monophosphates
AR084044A1 (es) 2010-11-30 2013-04-17 Pharmasset Inc Compuestos 2’-espiro-nucleosidos
CN102949406B (zh) * 2011-08-31 2014-03-12 天津药物研究院 一种复方艾夫他滨药物组合物及其制备方法和用途
AR089857A1 (es) * 2012-02-02 2014-09-24 Glaxosmithkline Llc Comprimido antiacido para refrescar el aliento
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
CN104069126A (zh) * 2014-07-02 2014-10-01 浙江康乐药业股份有限公司 一种治疗胃酸过多的药物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260596A (en) * 1979-08-13 1981-04-07 Bristol-Myers Company Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
JPS62501712A (ja) * 1985-08-26 1987-07-09 アメリカ合衆国 ２′、３′―ジデオキシイノシン、２′，３′―ジデオキシグアノシンまたは２′，３′―ジデオキシアデノシンを含有する抗ｈｔｌｖ―３／ｌａｖ剤
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
CH674148A5 (zh) * 1986-06-24 1990-05-15 Racz Istvan
WO1988002629A1 (en) * 1986-10-16 1988-04-21 American Health Products Corporation 2',3'-didesoxyadenosine composition
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5026687A (en) * 1990-01-03 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds

Also Published As

Publication number Publication date
GR3026332T3 (en) 1998-06-30
EP0524579A1 (en) 1993-01-27
PL295329A1 (en) 1993-04-05
ES2113389T3 (es) 1998-05-01
CA2074215C (en) 2001-12-18
NZ243567A (en) 1995-04-27
HU9202375D0 (en) 1992-10-28
KR930001912A (ko) 1993-02-22
MX9204256A (es) 1993-01-01
NO922807L (no) 1993-01-25
US5880106A (en) 1999-03-09
TW211521B (zh) 1993-08-21
AU657337B2 (en) 1995-03-09
RU2089193C1 (ru) 1997-09-10
FI923308A (fi) 1993-01-23
HU211285A9 (en) 1995-11-28
HU220612B1 (hu) 2002-03-28
DK0524579T3 (da) 1998-04-06
AU2039692A (en) 1993-01-28
NO922807D0 (no) 1992-07-16
CN1042299C (zh) 1999-03-03
JPH05194234A (ja) 1993-08-03
HUT61472A (en) 1993-01-28
KR960011772B1 (ko) 1996-08-30
NO300198B1 (no) 1997-04-28
HU9202318D0 (en) 1992-10-28
CA2074215A1 (en) 1993-01-23
FI923308A0 (fi) 1992-07-20
IL102519A (en) 1996-01-31
DE69224684D1 (de) 1998-04-16
IE922365A1 (en) 1992-11-18
DE69224684T2 (de) 1998-11-12
IL102519A0 (en) 1993-01-14
CN1068739A (zh) 1993-02-10
JP3038456B2 (ja) 2000-05-08
ZA925484B (en) 1993-09-13
ATE163855T1 (de) 1998-03-15
EP0524579B1 (en) 1998-03-11

Similar Documents

Publication Publication Date Title
FI105153B (fi) Menetelmä farmaseuttisten, suun kautta annettavien dideoksipuriininukleosidikoostumusten valmistamiseksi
FI77371C (fi) Foerfarande foer framstaellning av en kapsel, som innehaoller ett alkaliskt aemne och acetylsalicylsyra.
ES2301537T3 (es) Comprimidos y formulacion de guaifenesina de liberacion sostenida.
JP2008231120A (ja) アジスロマイシン投与法
JP2003519656A (ja) 新規な置換ベンズイミダゾール投与形態およびそれらの使用方法
EP2402003A2 (en) Diclofenac formulations and methods of use
NZ574331A (en) Liquid compositions of calcium acetate
EP2233147A1 (en) Salt solution for colon cleansing
CN101563071A (zh) 尼古丁经口粘膜剂型
CN108904808A (zh) 一种治疗便秘的药物组合物及其应用
JPH03206046A (ja) 腸管洗浄液用組成物及び腸管洗浄液
US6793935B2 (en) Mineral supplement
JPH05506238A (ja) 薬学的処方物
Ekenved et al. In vivo studies on the neutralizing effect of antacids using the Heidelberg capsule
CZ79593A3 (en) Antitussive preparation
WO2009092002A1 (en) Antiretroviral drug formulations for treatment of children exposed to hiv/aids
CN101972230A (zh) 吡非尼酮干混悬剂及制备
KR100367877B1 (ko) 구연산칼륨을 주제로 한 요로결석 치료제중 분말 및 미립제형 의 제조방법
EP0051207B1 (en) A pharmaceutical mixture containing sodium cromoglycate and a method of making the mixture
CN111511222B (zh) 用于钙补充的组合物
JPH11322606A (ja) 易嚥下性抗悪性腫瘍製剤
GB2086227A (en) Sodium cromoglycate reconstitutable powders
EA042006B1 (ru) Композиция в качестве добавки кальция
JPH11116495A (ja) 服用感の改善されたビタミン配合薬

Legal Events

Date Code Title Description
MA Patent expired